1u21

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1u21.gif|left|200px]]
[[Image:1u21.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1u21 |SIZE=350|CAPTION= <scene name='initialview01'>1u21</scene>, resolution 1.69&Aring;
+
The line below this paragraph, containing "STRUCTURE_1u21", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=P2C:2-[(3,5-DICHLORO-4-TRIOXIDANYLPHENYL)AMINO]BENZOIC+ACID'>P2C</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE= TTR; PALB; ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1u21| PDB=1u21 | SCENE= }}
-
|RELATEDENTRY=
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1u21 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1u21 OCA], [http://www.ebi.ac.uk/pdbsum/1u21 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1u21 RCSB]</span>
+
-
}}
+
'''transthyretin with tethered inhibitor on one monomer.'''
'''transthyretin with tethered inhibitor on one monomer.'''
Line 31: Line 28:
[[Category: Wilson, I A.]]
[[Category: Wilson, I A.]]
[[Category: Wiseman, R L.]]
[[Category: Wiseman, R L.]]
-
[[Category: amyloid]]
+
[[Category: Amyloid]]
-
[[Category: transthyretin]]
+
[[Category: Transthyretin]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 10:39:36 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 00:04:20 2008''
+

Revision as of 07:39, 3 May 2008

Template:STRUCTURE 1u21

transthyretin with tethered inhibitor on one monomer.


Overview

Protein native state stabilization imposed by small molecule binding is an attractive strategy to prevent the misfolding and misassembly processes associated with amyloid diseases. Transthyretin (TTR) amyloidogenesis requires rate-limiting tetramer dissociation before misassembly of a partially denatured monomer ensues. Selective stabilization of the native TTR tetramer over the dissociative transition state by small molecule binding to both thyroxine binding sites raises the kinetic barrier of tetramer dissociation, preventing amyloidogenesis. Assessing the amyloidogenicity of a TTR tetramer having only one amyloidogenesis inhibitor (I) bound is challenging because the two small molecule binding constants are generally not distinct enough to allow for the exclusive formation of TTR.I in solution to the exclusion of TTR.I(2) and unliganded TTR. Herein, we report a method to tether one fibril formation inhibitor to TTR by disulfide bond formation. Occupancy of only one of the two thyroxine binding sites is sufficient to inhibit tetramer dissociation in 6.0 M urea and amyloidogenesis under acidic conditions by imposing kinetic stabilization on the entire tetramer. The sufficiency of single occupancy for stabilizing the native state of TTR provides the incentive to search for compounds displaying striking negative binding cooperativity (e.g., K(d1) in nanomolar range and K(d2) in the micromolar to millimolar range), enabling lower doses of inhibitor to be employed in the clinic, mitigating potential side effects.

About this Structure

1U21 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Kinetic stabilization of an oligomeric protein by a single ligand binding event., Wiseman RL, Johnson SM, Kelker MS, Foss T, Wilson IA, Kelly JW, J Am Chem Soc. 2005 Apr 20;127(15):5540-51. PMID:15826192 Page seeded by OCA on Sat May 3 10:39:36 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools